GDE vs. VRNA

Last updated Jun 14, 2026

GDE (WisdomTree Efficient Gold Plus Equity Strategy Fund) is Gold fund actively managed by WisdomTree, while VRNA (Verona Pharma plc) is a stock. At a 0.20 correlation, their price movements are largely independent.

Performance

GDE vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GDE

• 1D: 0.67%
• 1M: -9.22%
• YTD: 3.16%
• 6M: 4.00%
• 1Y: 40.98%
• 3Y*: 42.64%
• 5Y*: —
• 10Y*: —

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GDE vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund	3.16%	73.76%	44.79%	33.85%	-8.58%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	434.36%

Correlation

The correlation between GDE and VRNA is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (All Time) Calculated using the full available price history since Mar 17, 2022	0.20

The correlation between GDE and VRNA shifts across timeframes, from 0.06 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Return for Risk

GDE vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GDE

GDE Risk / Return Rank: 42
GDE Sharpe Ratio Rank: 45
GDE Sortino Ratio Rank: 39
GDE Omega Ratio Rank: 46
GDE Calmar Ratio Rank: 41
GDE Martin Ratio Rank: 38

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GDE vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	GDE	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	1.39	—	—
Sortino ratio: Return per unit of downside risk	1.81	—	—
Omega ratio: Gain probability vs. loss probability	1.26	—	—
Calmar ratio: Return relative to maximum drawdown	1.83	—	—
Martin ratio: Return relative to average drawdown	5.36	—	—

Drawdowns

Drawdown Indicators

	GDE	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-32.01%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-22.66%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-22.66%	—	—
Current Drawdown Current decline from peak	-16.53%	—	—
Average Drawdown Average peak-to-trough decline	-7.93%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	7.73%	—	—

Volatility

Volatility by Period

	GDE	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.77%	—	—
Volatility (6M) Calculated over the trailing 6-month period	25.97%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	29.88%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.09%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.09%	—	—

Dividends

GDE vs. VRNA - Dividend Comparison

GDE's dividend yield for the trailing twelve months is around 4.19%, while VRNA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund	4.19%	4.32%	7.14%	2.22%	0.81%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both GDE and VRNA in my portfolio?

GDE and VRNA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.